CN218338809U - Drug delivery device for treating acute radiation proctoptositis - Google Patents
Drug delivery device for treating acute radiation proctoptositis Download PDFInfo
- Publication number
- CN218338809U CN218338809U CN202220490372.7U CN202220490372U CN218338809U CN 218338809 U CN218338809 U CN 218338809U CN 202220490372 U CN202220490372 U CN 202220490372U CN 218338809 U CN218338809 U CN 218338809U
- Authority
- CN
- China
- Prior art keywords
- long tube
- negative pressure
- pressure bottle
- vacuum negative
- gel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Landscapes
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
The utility model relates to a device of dosing for treating acute radiation proctoptoma, including vacuum negative pressure bottle, detachably set up vacuum negative pressure bottle lid of vacuum negative pressure bottle bottleneck department and with the detachable administration pipe subassembly of the side looks adaptation of vacuum negative pressure bottle lid, this detachable administration pipe subassembly includes long tube shower nozzle and gel long tube, is equipped with reflective coating on the outer wall of vacuum negative pressure bottle. Compared with the prior art, the utility model discloses use vacuum negative pressure bottle as the basis, set up removable long tube shower nozzle and gel long tube, obtain a convenient operation's the device of dosing that is used for treating acute radioactive rectal anal canal inflammation, the patient can operate repeatedly by oneself and control the dose of dosing, promotes the improvement of acute radioactive rectal anal canal inflammation to improve patient's quality of life.
Description
Technical Field
The utility model belongs to the technical field of rectum anal canal is dosed, a device of dosing for treating acute radiation rectum anal canal inflammation is related to.
Background
Pelvic radiotherapy is an important means in the treatment process of malignant tumors such as gynecological tumors, prostate tumors and rectal tumors, the local control rate of the tumors of a patient is improved, the disease-free survival time of the patient is prolonged, and meanwhile, a pelvic cavity before operation provides an operation opportunity for the patient who is not resectable initially, and the total survival of the patient is prolonged. However, pelvic radiotherapy also causes injuries of different degrees, about 75% of patients can suffer from acute radiation rectal anal canal injury in pelvic radiotherapy or within 3 months, acute radiation proctitis (RARI) is an independent prognostic factor of chronic radiation injury, and many patients suffer from low organ resection syndrome (LARS) after operation, which affects the functions of multiple organs such as stomach, intestine, reproduction and urinary organs. The research on various preoperative and novel adjuvant therapies of the rectum discovers that the occurrence of acute radioactive rectal injury is an independent risk factor of postoperative anastomotic leakage. Therefore, treatment of acute radioactive rectal anal canal injury is very important. At present, some treatment measures including montmorillonite powder, steroid and traditional Chinese medicine retention enema are provided in clinic, and certain curative effects are achieved, but retention enema is usually required for 30min-2 hours and 2 times per day, each time is 100-200ml, the clinical operation is difficult, and the home implementation repeatability of patients is poor.
The current research scheme of the drug delivery device for treating acute radiation proctoptomia generally adds a rectal drug delivery tube or a drug delivery device on the basis of a conventional syringe, and the drug delivery tube or the drug delivery device is not actually used, because: on one hand, the syringe plus rectal administration tube may cause drug to be inhaled back into the injection device due to the change of rectal pressure, and the administration efficacy is poor; on the other hand, the mode still needs medical staff or family members to assist the patient in drug administration, and the contradiction that the operation is not convenient is not solved.
SUMMERY OF THE UTILITY MODEL
The utility model aims at providing a device of dosing for treating acute radiation proctoptositis. The device is convenient for the patient to operate and use by oneself, and is easy and simple to handle, efficient, and patient is good at home repeatability, and is applicable to clinical multiple drug form, is suitable for wide application.
The purpose of the utility model can be realized through the following technical scheme:
the utility model provides a device of dosing for treating acute radioactive rectum anal canal inflammation, the device include vacuum negative pressure bottle, detachably set up vacuum negative pressure bottle lid of vacuum negative pressure bottle bottleneck department and with the detachable pipe subassembly of dosing of the side looks adaptation of vacuum negative pressure bottle lid, this detachable pipe subassembly of dosing includes long tube shower nozzle and gel long tube, the outer wall of vacuum negative pressure bottle on be equipped with reflective coating. The medicine is filled into a vacuum negative pressure bottle, the bottle cap of the vacuum negative pressure bottle is covered, and a long pipe spray head or a gel long pipe is selected as required, and then the medicine can be sprayed on the affected part. Wherein, the long tube spray head is suitable for liquid medicine, and the gel long tube is suitable for gel medicine. The reflective coating is preferably a silver ion reflective coating to reduce thermal radiation of the drug inside the vacuum negative pressure vial.
Furthermore, the side of the bottle cap of the vacuum negative pressure bottle is provided with a connecting interface, and the long pipe nozzle and the gel long pipe are matched with the connecting interface. The long tube spray head or the gel long tube is arranged on the vacuum negative pressure bottle cap through the connecting interface.
Furthermore, the connecting interface is detachably connected with the long tube spray head or the gel long tube. The long tube spray head or the gel long tube can be arranged at the connecting interface according to the requirement.
Further, the connecting interface is rotatably connected with the long tube spray head or the gel long tube. The long pipe spray head or the gel long pipe can be rotated to different directions so as to facilitate spraying.
Furthermore, the long pipe nozzle comprises a long pipe nozzle connecting part matched with the connecting interface, a nozzle connecting long pipe and a nozzle, one end of the nozzle connecting long pipe is connected with the long pipe nozzle connecting part, and the other end of the nozzle connecting long pipe is connected with the nozzle. When in use, the liquid medicine in the vacuum negative pressure bottle enters the nozzle to be connected with the long tube and is sprayed out through the nozzle.
Furthermore, the gel long tube comprises a gel long tube connecting part matched with the connecting interface and a porous long tube connected with the gel long tube connecting part, and a plurality of gel drainage holes are distributed on the side wall of the porous long tube. When the vacuum negative pressure bottle is used, the gel medicine in the vacuum negative pressure bottle enters the porous long tube and flows out through each gel drainage hole.
Further, the pore diameters of the plurality of gel drainage holes are gradually increased along the flow direction of the medicine.
Furthermore, the outer wall of the vacuum negative pressure bottle is provided with an uncoated area, and the uncoated area is provided with scales. The scale can facilitate the patient to read each dosage to control the administration dosage.
Furthermore, an insulating layer is arranged outside the reflecting coating. The heat insulation layer is preferably PVC heat insulation layer for further heat insulation.
Further, the device also comprises a bottle cap protective cover matched with the vacuum negative pressure bottle cap and the detachable administration tube assembly, and a yielding groove is formed in the bottle cap protective cover. The yielding groove is used for avoiding the connecting interface, the long pipe spray head connecting part or the gel long pipe connecting part.
Compared with the prior art, the utility model has the characteristics of it is following:
1) The vacuum negative pressure bottle is used as a basis, the replaceable long tube nozzle and the gel long tube are arranged, the administration device for treating the acute radioactive proctoptosis is convenient to operate, a patient can repeatedly operate and control the administration dosage by himself, the improvement of the acute radioactive proctoptosis is promoted, and therefore the life quality of the patient is improved.
2) The utility model is suitable for various clinical drug formulations, including liquid and gel; the medicine is convenient to store, and the failure is avoided; the bottle body can be used by turning upside down; can be carried about and repeatedly used without the assistance of others.
Drawings
Fig. 1 is a schematic front view of the vacuum negative pressure bottle and the vacuum negative pressure bottle cap of the present invention after being assembled;
fig. 2 is a left side view structure diagram of the vacuum negative pressure bottle and the vacuum negative pressure bottle cap of the present invention after being assembled;
FIG. 3 is a schematic structural view of the long pipe nozzle of the present invention after installation;
FIG. 4 is a left side view of the long pipe nozzle of the present invention;
FIG. 5 is a schematic structural view of the utility model after the installation of the gel long tube;
FIG. 6 is a left side view of the gel long tube of the present invention;
fig. 7 is a schematic front view of the protective cover of the bottle cap according to the present invention;
the notation in the figure is:
the device comprises 1-vacuum negative pressure bottle, 2-vacuum negative pressure bottle cap, 3-reflective coating, 4-connecting port, 5-long pipe spray nozzle connecting part, 6-spray nozzle connecting long pipe, 7-spray nozzle, 8-gel long pipe connecting part, 9-porous long pipe, 10-gel drainage hole, 11-uncoated area, 12-scale, 13-heat preservation layer, 14-bottle cap protective cap and 15-abdicating groove.
Detailed Description
The present invention will be described in detail below with reference to the accompanying drawings and specific embodiments. The embodiment is implemented on the premise of the technical solution of the present invention, and a detailed implementation manner and a specific operation process are given, but the scope of the present invention is not limited to the following embodiments.
Example (b):
as shown in fig. 1 and fig. 2, the drug delivery device for treating acute radiation proctoptoma comprises a vacuum negative pressure bottle 1, a vacuum negative pressure bottle cap 2 detachably arranged at the bottleneck of the vacuum negative pressure bottle 1, and a detachable drug delivery tube component adapted to the side surface of the vacuum negative pressure bottle cap 2, wherein the detachable drug delivery tube component comprises a long tube sprayer and a gel long tube, and a reflective coating 3 is arranged on the outer wall of the vacuum negative pressure bottle 1. The outer wall of the vacuum negative pressure bottle 1 is provided with an uncoated area 11, and the uncoated area 11 is provided with a scale 12. The reflective coating 3 is provided with an insulating layer 13 on the outside.
Wherein, the side of the vacuum negative pressure bottle cap 2 is provided with a connecting interface 4, and the long tube spray head and the gel long tube are matched with the connecting interface 4. The connecting interface 4 is detachably connected with the long pipe spray head or the gel long pipe, and the connecting interface 4 is rotatably connected with the long pipe spray head or the gel long pipe.
As shown in fig. 3 and 4, the long pipe nozzle includes a long pipe nozzle connecting portion 5 adapted to the connection interface 4, a nozzle connecting long pipe 6, and a nozzle 7, wherein one end of the nozzle connecting long pipe 6 is connected to the long pipe nozzle connecting portion 5, and the other end is connected to the nozzle 7.
As shown in fig. 5 and 6, the gel long tube comprises a gel long tube connecting part 8 matched with the connecting interface 4 and a porous long tube 9 connected with the gel long tube connecting part 8, and a plurality of gel drainage holes 10 are distributed on the side wall of the porous long tube 9. The pore diameter of the plurality of gel drainage pores 10 gradually increases in the direction of the flow of the drug.
As shown in fig. 7, the device further comprises a cap protection cover 14 adapted to the vacuum negative pressure bottle cap 2 and the detachable administration tube assembly, wherein the cap protection cover 14 is provided with a relief groove 15.
When in use, the bottle cap 2 of the vacuum negative pressure bottle is opened, liquid medicine or gel medicine is added into the vacuum negative pressure bottle 1, and then the bottle cap 2 of the vacuum negative pressure bottle is covered and a long pipe nozzle or a gel long pipe is selectively installed; bending down the patient, exposing the damaged part, smearing appropriate amount of vaseline or aureomycin eye ointment on the surface of the long tube spray head or gel long tube for lubrication, and then placing the anus and spraying on the affected part. RTOG (tenesmus, mucous, diarrhea) is indicated in cases of grade 1-2 acute radiation proctoptomia.
The embodiments described above are intended to facilitate the understanding and use of the invention by those skilled in the art. It will be readily apparent to those skilled in the art that various modifications to these embodiments may be made, and the generic principles described herein may be applied to other embodiments without the use of the inventive faculty. Therefore, the present invention is not limited to the above embodiments, and those skilled in the art should make improvements and modifications within the scope of the present invention according to the disclosure of the present invention.
Claims (10)
1. The utility model provides a device of dosing for treating acute radioactive proctoptositis, its characterized in that, the device include vacuum negative pressure bottle (1), detachably set up vacuum negative pressure bottle lid (2) of vacuum negative pressure bottle (1) bottleneck department and with the detachable administration tube subassembly of the side looks adaptation of vacuum negative pressure bottle lid (2), this detachable administration tube subassembly includes long tube shower nozzle and long tube gel, the outer wall of vacuum negative pressure bottle (1) on be equipped with reflective coating (3).
2. The drug delivery device for treating acute radiation proctoptosis and anal canal inflammation according to claim 1, wherein the side of the vacuum negative pressure bottle cap (2) is provided with a connection interface (4), and the long tube spray head and the gel long tube are both adapted to the connection interface (4).
3. The drug delivery device for treating acute radiation proctoptosis as claimed in claim 2, wherein the connection interface (4) is detachably connected with a long tube spray head or a gel long tube.
4. The drug delivery device for treating acute radiation proctoptosis as claimed in claim 2, wherein the connection interface (4) is rotatably connected with a long tube spray head or a gel long tube.
5. The drug delivery device for treating acute radiation proctoptosis and anal canal inflammation according to claim 2, wherein the long tube nozzle comprises a long tube nozzle connecting part (5) matched with the connecting interface (4), a nozzle connecting long tube (6) and a nozzle (7), one end of the nozzle connecting long tube (6) is connected with the long tube nozzle connecting part (5), and the other end is connected with the nozzle (7).
6. The drug delivery device for treating the acute radiation proctoptosis and anal canal inflammation as claimed in claim 2, wherein the gel long tube comprises a gel long tube connecting part (8) matched with the connecting interface (4) and a porous long tube (9) connected with the gel long tube connecting part (8), and a plurality of gel drainage holes (10) are distributed on the side wall of the porous long tube (9).
7. The drug delivery device for treating acute radiation proctoptosis according to claim 6, wherein the pore size of the plurality of gel drainage holes (10) is gradually increased along the drug flow direction.
8. The drug delivery device for treating acute radiation proctoptosis according to claim 1, wherein the outer wall of the vacuum bottle (1) is provided with an uncoated area (11), and the uncoated area (11) is provided with a scale (12).
9. The device for the treatment of acute radiation proctoptosis as claimed in claim 1, wherein said reflective coating (3) is externally provided with an insulating layer (13).
10. The drug delivery device for treating acute radiation proctoptosis according to claim 1, further comprising a cap protection cap (14) adapted to the vacuum negative pressure bottle cap (2) and the detachable drug delivery tube assembly, wherein the cap protection cap (14) is provided with an abdicating groove (15).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202220490372.7U CN218338809U (en) | 2022-03-08 | 2022-03-08 | Drug delivery device for treating acute radiation proctoptositis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202220490372.7U CN218338809U (en) | 2022-03-08 | 2022-03-08 | Drug delivery device for treating acute radiation proctoptositis |
Publications (1)
Publication Number | Publication Date |
---|---|
CN218338809U true CN218338809U (en) | 2023-01-20 |
Family
ID=84922479
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202220490372.7U Active CN218338809U (en) | 2022-03-08 | 2022-03-08 | Drug delivery device for treating acute radiation proctoptositis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN218338809U (en) |
-
2022
- 2022-03-08 CN CN202220490372.7U patent/CN218338809U/en active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1585571B1 (en) | Vaginal or rectal applicator and method | |
RU2570937C2 (en) | Catheter, particularly indwelling catheter for treating urinary bladder and/or prostate functional disorders and/or diseases | |
CN108478922A (en) | A kind of section office of gynemetrics vaginal administration device | |
CN218338809U (en) | Drug delivery device for treating acute radiation proctoptositis | |
CN109498973A (en) | A kind of medicine sprayer for respiratory medical department | |
CN206508369U (en) | One uterine cryptomere support tube | |
CN108619612A (en) | A kind of special rectum medicine applying apparatus of GI Medicine | |
CN211158090U (en) | Special gynecological medicine applicator | |
CN207323830U (en) | A kind of simple self-service urethreurynter | |
US20040249364A1 (en) | Device and method for dispensing medication to tissue lining a body cavity | |
CN208448388U (en) | A kind of novel catheter apparatus | |
CN210583336U (en) | Prostate medicine-guiding tube | |
CN107174726A (en) | A kind of implanted chemotherapy infusion system for being used to treat carcinoma of urinary bladder | |
CN208809290U (en) | Vagina pinpoints administration injection device | |
CN208339915U (en) | A kind of irrigation of bladder device | |
CN213589498U (en) | Cervical drug delivery device | |
CN215194894U (en) | Disposable gynecological medicine applicator | |
CN206652082U (en) | A kind of delivery device | |
CN208660124U (en) | A kind of gynemetrics's drug delivery device | |
CN216258697U (en) | Novel gynaecology is with regional vagina of target device of dosing | |
CN213491452U (en) | Cervical ware of dosing for gynaecology's treatment | |
CN220558408U (en) | Ear, nose and throat medicine feeder | |
CN215690935U (en) | Gynecological inflammation drug applicator | |
CN220824256U (en) | Multifunctional postoperative tamponade for anus operation | |
CN218305775U (en) | Medicine device that spouts that anesthesia branch of academic or vocational study operation nursing was used |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GR01 | Patent grant | ||
GR01 | Patent grant |